Follow-up of primary melanoma patients with high risk of recurrence: recommendations based on evidence and consensus
- 28 March 2022
- journal article
- review article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 24 (8) , 1515-1523
Abstract
In spite of the good prognosis of patients with early-stage melanoma, there is a substantial proportion of them that develop local or distant relapses. With the introduction of targeted and immune therapies for advanced melanoma, including at the adjuvant setting, early detection of recurrent melanoma and/or second primary lesions is crucial to improve clinical outcomes. However, there is a lack of universal guidelines regarding both frequency of surveillance visits and diagnostic imaging and/or laboratory evaluations. In this article, a multidisciplinary expert panel recommends, after careful review of relevant data in the field, a consensus- and experience-based follow-up strategy for melanoma patients, taking into account prognostic factors and biomarkers and the high-risk periods and patterns of recurrence in each (sub) stage of the disease. Apart from the surveillance intensity, healthcare professionals should focus on patients’ education to perform regular self-examinations of the skin and palpation of lymph nodes.Keywords
Funding Information
- Novartis Pharma
This publication has 80 references indexed in Scilit:
- Prediction of Survival in Patients With Thin Melanoma: Results From a Multi-Institution StudyJournal of Clinical Oncology, 2014
- Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged SkinJournal of Clinical Oncology, 2013
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 MutationsNew England Journal of Medicine, 2012
- Melanoma Genetics: Recent Findings Take Us Beyond Well-Traveled PathwaysJournal of Investigative Dermatology, 2012
- Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma RegistryJournal of the American Academy of Dermatology, 2012
- Can 18F-FDG PET/CT predict recurrence in patients with cutaneous malignant melanoma?Nuklearmedizin-Nuclear Medicine, 2011
- Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?Melanoma Research, 2010
- Selection criteria for genetic assessment of patients with familial melanomaJournal of the American Academy of Dermatology, 2009
- Sun protection and skin self‐examination in melanoma survivorsPsycho-Oncology, 2009
- Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical settingBritish Journal of Dermatology, 2008